Ocul Immunol Inflamm . Uveitis and Posterior Ophthalmic Manifestations Following the SARS-CoV-2 (COVID-19) Vaccine

[tetano]

Ocul Immunol Inflamm


. 2022 Jun 28;1-7.
doi: 10.1080/09273948.2022.2079533. Online ahead of print.
Uveitis and Posterior Ophthalmic Manifestations Following the SARS-CoV-2 (COVID-19) Vaccine


Kishan G Patel ¹ , Taylor Hilton ² , Rene Y Choi ² , Ashkan M Abbey ²



Affiliations

• PMID: 35763603
• DOI: 10.1080/09273948.2022.2079533

Abstract

Purpose: To present four cases of posterior ophthalmic manifestations associated with a temporal relationship to SARS-CoV-2 vaccination.
Methods: Retrospective case series with a review of clinical findings.
Results: Four patients presented with various posterior ophthalmic findings including uveitis, maculopathy, and optic neuropathy. Each of their clinical courses varied in terms of ophthalmic imaging and exam findings.
Conclusion: The coronavirus disease 2019 (COVID-19) pandemic has ushered in a new wave of challenges to healthcare, epidemiological endeavors, and widespread vaccination efforts. Novel vaccines have been developed for the SARS-CoV-2 virus, including both mRNA and viral vector-based platforms. The ocular manifestations and side effects related to the SARS-CoV-2 vaccine is not well established or understood. There may be an association between vaccination and posterior ophthalmic manifestations.

Keywords: COVID-19; Coronavirus; inflammation; mRNA; maculopathy; optic neuropathy; pandemic; uveitis; vaccination; viral.

[sharon sanders]

bump this